Managed Health Care

Analysts at Capstone initiate coverage of Magellan Health Services Inc (NASDAQ: MGLN) with a “buy” rating. The target price for MGLN is set to $55. MGLN shares gained 0.52% to close at $46.33 yesterday. More Analyst Ratings here

Jefferies has issued a Hold Rating and $33.00 PT for Coventry Health Care (CVH). According to Jefferies, " We are initiating coverage with a Hold rating and a $33 price target. Like many other managed care companies, Coventry has benefitted from low utilization; however, Healthcare Reform poses...

Jefferies has reported on Heath Net, Inc's (NYSE: HNT) rating and Price Target. In the report Jefferies writes, "We are initiating coverage with a Hold rating and $32 price target. Valuation dissuades us from being more positive as HNT is trading in-line with its historical average P/E and at...

CIGNA (NYSE: CI) and EMD Serono, Inc. have entered into the nation's first outcomes-based contract for a specialty medication, aimed at improving the health of people with multiple sclerosis (MS). The CIGNA and EMD Serono contract is designed to help people with multiple sclerosis prevent...

In a report published by Citi, Universal American (NYSE: UAM) is the only stock in the managed care group trading below the net cash held on the balance sheet. Citi said that Pro forma tangible book value at year end was nearly $10 per share, better than the $8 it expected. “With $10 in tangible...

Citi is providing some analysis on the CIGNA Corporation (NYSE: CI) investor day. “CIGNA argued that their pricing hasn't been overly aggressive,” Citi writes. “Still, it's hard to get comfortable, considering that CIGNA was the only plan to grow risk membership last year, while CIGNA is routinely...

Health Net, Inc. (NYSE: HNT) today announced that it is conducting an investigation into several server drives that are unaccounted for from its data center operation located in Rancho Cordova, Calif. This investigation follows notification by IBM, Health Net's vendor responsible for managing...

On Friday, CIGNA Corporation (NYSE: CI) held an investor day, reiterating the already established key '11 guidance points and also setting a long-term EPS growth target at 10-13%, J.P. Morgan reports. J.P. Morgan said that among some of the key themes it noted: “1) The International business...

By Josh Lipton In the past month, while violent unrest in the Middle East and North Africa has dramatically dominated the investment headlines, strategists note that one sector has quietly emerged under the radar: Health Care. In fact, month-to-date, the S&P 500 is down .41%. However, there...

J.P. Morgan is out with its report today on WellCare Health Plans (NYSE: WCG), maintaining Neutral. In a note to clients, J.P. Morgan writes, "We consider some premium valuation to the state program/Medicaid businesses (this representing somewhat over half of WCG's top line), which are those most...

By Jared Rosenbaum Aloha ahiahi,So off I go on vacation and apparently the market decided this was a good time to make massive moves up and down every single day. Fortunately for me, the market opened at 4:30am here, which allowed me to watch most of the trading session before anybody was really...

On Friday, Aetna Inc. (NYSE: AET) held its investor day, J.P. Morgan reports. Among the key takeaways, J.P. Morgan noted the following. “1) Citing ‘increasing comfort' with '11 earnings view,” J.P. Morgan writes.” “2) A considerable focus on international opportunities, and beyond just expat, with...

Deutsche Bank has a Buy rating and a $46 price target on shares of Aetna (NYSE: AET) after the company held its investor conference. In a note to investors, Deutsche Bank writes, "Aetna kicked off the meeting by noting that 2011 is off to a good start and that it now has increased confidence in...

J.P. Morgan is out with its report today on AmeriGroup (NYSE: AGP), raising its PT from $49 to $62. In a note to clients, J.P. Morgan writes, "Our December2011 price target of $62/share (prior $49) is derived by applying a 14.5x (prior 12.5x) multiple to our 2012 earnings estimate, which compares...

JP Morgan has raised the price target on AmeriGroup Corporation (NYSE: AGP) from $49 to $62 and maintains its Neutral rating.